Pathways in physiological and pathological hypertrophy of the heart. Largely based on the article from [https://www.ncbi.nlm.nih.gov/pubmed/11714087 Wang et al, 'Signal transduction in cardiac hypertrophy--dissecting compensatory versus pathological pathways utilizing a transgenic approach.] Hypertrohpy of the heart can be a physiological compensation for exercise, but it can also be a pathological compensation for hypertension and stress. Proteins on this pathway have targeted assays available via the [https://assays.cancer.gov/available_assays?wp_id=WP1528 CPTAC Assay Portal] a6d ca4 a68 e1a ed4 be1 c5f e83 ebd efd e1a b2b ad7 e83 b12 d0a a29 ad7 e83 10528039 PubMed Signaling pathways for cardiac hypertrophy and failure. N Engl J Med 1999 Hunter JJ Chien KR hypertrophic cardiomyopathy DOID:11984 Disease 8621626 PubMed Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways. J Biol Chem 1996 Wollert KC Taga T Saito M Narazaki M Kishimoto T Glembotski CC Vernallis AB Heath JK Pennica D Wood WI Chien KR 10086361 PubMed Calcineurin and human heart failure. Nat Med 1999 Lim HW Molkentin JD 9253712 PubMed Cardiotrophin-1 and the role of gp130-dependent signaling pathways in cardiac growth and development. J Mol Med 1997 Wollert KC Chien KR cardiac muscle cell CL:0000746 Cell Type 10952417 PubMed Advances in the molecular mechanisms of heart failure. Curr Opin Cardiol 2000 MacLellan WR 11055975 PubMed Calcineurin and beyond: cardiac hypertrophic signaling. Circ Res 2000 Molkentin JD 10189350 PubMed Prevention of cardiac hypertrophy by calcineurin inhibition: hope or hype? Circ Res 1999 Olson EN Molkentin JD 10864911 PubMed Transgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophy. Circ Res 2000 Takeishi Y Ping P Bolli R Kirkpatrick DL Hoit BD Walsh RA 16936699 PubMed Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat Rev Mol Cell Biol 2006 Heineke J Molkentin JD heart disease DOID:114 Disease 9568714 PubMed A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 1998 Molkentin JD Lu JR Antos CL Markham B Richardson J Robbins J Grant SR Olson EN 10615383 PubMed Signal transduction during cardiac hypertrophy: the role of G alpha q, PLC beta I, and PKC. Cardiovasc Res 1999 Jalili T Takeishi Y Walsh RA 11714087 PubMed Signal transduction in cardiac hypertrophy--dissecting compensatory versus pathological pathways utilizing a transgenic approach. Curr Opin Pharmacol 2001 Wang Y 9488659 PubMed Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells. J Biol Chem 1998 Wang Y Su B Sah VP Brown JH Han J Chien KR hypertrophic cardiomyopathy pathway PW:0000296 Pathway Ontology 10827130 PubMed Small guanine nucleotide-binding proteins and myocardial hypertrophy. Circ Res 2000 Clerk A Sugden PH 11101507 PubMed The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 2000 Bueno OF De Windt LJ Tymitz KM Witt SA Kimball TR Klevitsky R Hewett TE Jones SP Lefer DJ Peng CF Kitsis RN Molkentin JD